UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

RedundancyMiner: De-replication of redundant GO categories in microarray and proteomics analysis

BMC bioinformatics, 2011-02, Vol.12 (1), p.52-52, Article 52

2011

Volltextzugriff (PDF)

Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase

Cell cycle (Georgetown, Tex.), 2010-03, Vol.9 (5), p.995-1004

2010

Volltextzugriff (PDF)

Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells

Molecular cancer therapeutics, 2007-02, Vol.6 (2), p.391-403

2007

Volltextzugriff (PDF)

Using drug response data to identify molecular effectors, and molecular “omic” data to identify candidate drugs in cancer

Human genetics, 2015-01, Vol.134 (1), p.3-11

2015

Volltextzugriff (PDF)

Multifactorial regulation of E-cadherin expression: an integrative study

Molecular cancer therapeutics, 2010-01, Vol.9 (1), p.1-16

2010

Volltextzugriff (PDF)

Abstract IA21: PARP trapping and Schlafen 11 to kill cancer cells

Clinical cancer research, 2018-01, Vol.24 (1_Supplement), p.IA21-IA21

2018

Volltextzugriff (PDF)

Abstract B189: New class of TOP1 inhibitors selective for HR deficiencies and SLFN11 expression

Molecular cancer therapeutics, 2018-01, Vol.17 (1_Supplement), p.B189-B189

2018

Volltextzugriff (PDF)

Abstract PL05-04: PARP trapping versus PARP catalytic inhibition and coupling with TDP1

Molecular cancer therapeutics, 2015-12, Vol.14 (12_Supplement_2), p.PL05-04-PL05-04

2015

Volltextzugriff (PDF)

Effects of acetylation, polymerase phosphorylation, and DNA unwinding in glucocorticoid receptor transactivation

The Journal of steroid biochemistry and molecular biology, 2006-07, Vol.100 (1), p.3-17

2006

Volltextzugriff (PDF)

Etoposide Metabolites Enhance DNA Topoisomerase II Cleavage near Leukemia-Associated MLL Translocation Breakpoints

Biochemistry (Easton), 2001-02, Vol.40 (5), p.1159-1170

2001

Volltextzugriff (PDF)

Abstract CN05-03: Precision therapeutics with DNA-damaging agents

Molecular cancer therapeutics, 2018-01, Vol.17 (1_Supplement), p.CN05-03-CN05-03

2018

Volltextzugriff (PDF)

Abstract 3421: Differential potentiation of temozolomide and camptothecin by the PARP inhibitors olaparib and veliparib in relationship with their PARP-DNA trapping abilities, and lack of impact of PARP inhibitors on cisplatin activity

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.3421-3421

2013

Volltextzugriff (PDF)

Abstract LB167: Acetalax (Oxyphenisatin acetate, NSC 59687) and bisacodyl (dulcolax) cause oncosis in triple negative breast cancer by poisoning the ion exchange membrane protein TRPM4

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.LB167-LB167

2024

Volltextzugriff (PDF)

Abstract CN08-04: Novel topoisomerase I inhibitors in development

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.CN08-04-CN08-04

Pommier, Yves G.

2009

Volltextzugriff (PDF)

Abstract 4689: Stabilization of PARP-DNA complexes plays a critical role for the cytotoxic effects of the PARP inhibitors, veliparib and oliparib

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.4689-4689

2012

Volltextzugriff (PDF)

Abstract CN05-01: PARP inhibitors: Trapping of PARP and rational for combinations

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.CN05-01-CN05-01

2013

Volltextzugriff (PDF)

Abstract C204: Potentiation of the novel topoisomerase I inhibitor indenoisoquinoline LMP-400 by the Chk1/2 inhibitor, AZD7762

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.C204-C204

2011

Volltextzugriff (PDF)

RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I

Cancer research (Chicago, Ill.), 1996-04, Vol.56 (7), p.1674-1681

1996

Volltextzugriff (PDF)

Abstract 3620: A multiplex quantitative immunofluorescence assay for DNA damage repair in response to cytotoxic treatment

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3620-3620

2012

Volltextzugriff (PDF)

Abstract 3051: mRNA and microRNA expression profiles integrated with drug sensitivities of the NCI-60 human cancer cell lines

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3051-3051

2010

Volltextzugriff (PDF)

Associate Editor

Journal of experimental therapeutics & oncology, 2003-03, Vol.3 (2), p.58-58

Pommier, Yves G.

2003

Volltextzugriff (PDF)

Incorporation of a fluorescent guanosine analog into olignoucleotides and its application to a real time assay for the HIV-1 integrase 3′-Processing reaction

Nucleic acids research, 1995-08, Vol.23 (15), p.2872-2880

1995

Volltextzugriff (PDF)

Sensitizing human colon carcinoma HT-29 cells to cisplatin by cyclopentenylcytosine, in vitro and in vivo

Life sciences (1973), 2000-11, Vol.68 (1), p.1-11

2000

Volltextzugriff (PDF)

Predicting expression-related features of chromosomal domain organization with network-structured analysis of gene expression and chromosomal location

Proceedings of the ACM Conference on Bioinformatics, Computational Biology and Biomedicine, 2012, p.226-233

2012

Volltextzugriff (PDF)

The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin

Nature cell biology, 2022-01, Vol.24 (1), p.62-73

2022

Volltextzugriff (PDF)

1 – 25 von 210

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(205)
Mit Volltextzugriff
(196)

Publikationsform

Sprache

Englisch
(210)
Japanisch
(49)

Erscheinungsjahr

n.n

Thema

Science & Technology
(167)
Life Sciences & Biomedicine
(150)
Humans
(120)
Biological And Medical Sciences
(69)
Medical Sciences
(58)
Pharmacology & Pharmacy
(56)
Pharmacology. Drug Treatments
(55)
Dna Topoisomerases, Type I - Metabolism
(48)
Animals
(47)
Biochemistry & Molecular Biology
(47)
Antineoplastic Agents - Pharmacology
(42)
Oncology
(41)
Antineoplastic Agents
(38)
Base Sequence
(38)
Structure-Activity Relationship
(38)
Topoisomerase I Inhibitors
(38)
Camptothecin - Pharmacology
(35)
Dna Damage
(35)
Molecular Sequence Data
(35)
Chemistry, Medicinal
(34)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

RedundancyMiner: De-replication of redundant GO categories in microarray and proteomics analysis

Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase

Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells

Using drug response data to identify molecular effectors, and molecular “omic” data to identify candidate drugs in cancer

Multifactorial regulation of E-cadherin expression: an integrative study

Abstract IA21: PARP trapping and Schlafen 11 to kill cancer cells

Abstract B189: New class of TOP1 inhibitors selective for HR deficiencies and SLFN11 expression

Abstract PL05-04: PARP trapping versus PARP catalytic inhibition and coupling with TDP1

Effects of acetylation, polymerase phosphorylation, and DNA unwinding in glucocorticoid receptor transactivation

Etoposide Metabolites Enhance DNA Topoisomerase II Cleavage near Leukemia-Associated MLL Translocation Breakpoints

Abstract CN05-03: Precision therapeutics with DNA-damaging agents

Abstract 3421: Differential potentiation of temozolomide and camptothecin by the PARP inhibitors olaparib and veliparib in relationship with their PARP-DNA trapping abilities, and lack of impact of PARP inhibitors on cisplatin activity

Abstract LB167: Acetalax (Oxyphenisatin acetate, NSC 59687) and bisacodyl (dulcolax) cause oncosis in triple negative breast cancer by poisoning the ion exchange membrane protein TRPM4

Abstract CN08-04: Novel topoisomerase I inhibitors in development

Abstract 4689: Stabilization of PARP-DNA complexes plays a critical role for the cytotoxic effects of the PARP inhibitors, veliparib and oliparib

Abstract CN05-01: PARP inhibitors: Trapping of PARP and rational for combinations

Abstract C204: Potentiation of the novel topoisomerase I inhibitor indenoisoquinoline LMP-400 by the Chk1/2 inhibitor, AZD7762

RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I

Abstract 3620: A multiplex quantitative immunofluorescence assay for DNA damage repair in response to cytotoxic treatment

Abstract 3051: mRNA and microRNA expression profiles integrated with drug sensitivities of the NCI-60 human cancer cell lines

Associate Editor

Incorporation of a fluorescent guanosine analog into olignoucleotides and its application to a real time assay for the HIV-1 integrase 3′-Processing reaction

Sensitizing human colon carcinoma HT-29 cells to cisplatin by cyclopentenylcytosine, in vitro and in vivo

Predicting expression-related features of chromosomal domain organization with network-structured analysis of gene expression and chromosomal location

The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin

Suchergebnisse filtern